Eastman Chemical (EMN) Financials

$75.80 -5.02 (-6.21%)

Closing price 03:59 PM Eastern

Extended Trading

$75.84 +0.04 (+0.05%)

As of 05:47 PM Eastern

Annual Income Statements for Eastman Chemical

This table shows Eastman Chemical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	848	854	1,384	1,080	759	478	857	793	894	905
Consolidated Net Income / (Loss)	854	859	1,388	1,084	762	489	867	796	896	908
Net Income / (Loss) Continuing Operations	854	859	1,388	1,084	762	489	867	796	896	908
Total Pre-Tax Income	1,129	1,049	1,289	1,310	902	530	1,082	977	1,087	1,078
Total Operating Income	1,384	1,382	1,399	1,478	1,120	868	1,281	1,159	1,302	1,278
Total Gross Profit	2,580	2,357	2,363	2,479	2,234	1,975	2,500	2,137	2,061	2,290
Total Revenue	9,648	9,008	9,549	10,151	9,273	8,473	10,476	10,580	9,210	9,382
Operating Revenue	9,648	9,008	9,549	10,151	9,273	8,473	10,476	10,580	9,210	9,382
Total Cost of Revenue	7,068	6,651	7,186	7,672	7,039	6,498	7,976	8,443	7,149	7,092
Operating Cost of Revenue	7,068	6,651	7,186	7,672	7,039	6,498	7,976	8,443	7,149	7,092
Total Operating Expenses	1,196	975	964	1,001	1,111	1,107	1,096	935	1,082	1,012
Selling, General & Admin Expense	771	707	729	721	691	654	795	726	727	736
Research & Development Expense	242	223	227	235	234	226	254	264	239	250
Other Operating Expenses / (Income)	-	-	-	-	63	-	-	-6.00	38	47
Restructuring Charge	183	45	8.00	45	126	227	47	-49	78	-21
Total Other Income / (Expense), net	-255	-333	-110	-168	-218	-338	-322	-225	108	-200
Interest Expense	263	340	241	242	218	211	199	182	215	200
Other Income / (Expense), net	8.00	7.00	131	74	0.00	-127	-123	-43	323	0.00
Income Tax Expense	275	190	-99	226	140	41	215	181	191	170
Net Income / (Loss) Attributable to Noncontrolling Interest	6.00	5.00	4.00	4.00	3.00	11	10	3.00	2.00	3.00
Basic Earnings per Share	$5.71	$5.80	$9.56	$7.65	$5.52	$3.53	$6.35	$6.42	$7.54	$7.75
Weighted Average Basic Shares Outstanding	148.60M	147.30M	144.80M	15.43B	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Diluted Earnings per Share	$5.66	$5.75	$9.47	$7.56	$5.48	$3.50	$6.25	$6.35	$7.49	$7.67
Weighted Average Diluted Shares Outstanding	148.60M	147.30M	144.80M	15.43B	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Weighted Average Basic & Diluted Shares Outstanding	148.60M	147.30M	144.80M	15.43B	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Cash Dividends to Common per Share	$1.66	$1.89	$2.09	$2.30	$2.52	$2.67	$2.83	$3.07	$3.18	$3.26

This table shows Eastman Chemical's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	301	1.00	134	272	178	310	165	230	180	330
Consolidated Net Income / (Loss)	301	2.00	134	272	179	311	165	231	181	331
Net Income / (Loss) Continuing Operations	301	2.00	134	272	179	311	165	231	181	331
Total Pre-Tax Income	281	28	194	269	199	425	214	287	280	297
Total Operating Income	324	122	246	323	256	477	263	337	329	349
Total Gross Profit	541	376	529	584	484	464	532	599	605	554
Total Revenue	2,709	2,373	2,412	2,324	2,267	2,207	2,310	2,363	2,464	2,245
Operating Revenue	2,709	2,373	2,412	2,324	2,267	2,207	2,310	2,363	2,464	2,245
Total Cost of Revenue	2,168	1,997	1,883	1,740	1,783	1,743	1,778	1,764	1,859	1,691
Operating Cost of Revenue	2,168	1,997	1,883	1,740	1,783	1,743	1,778	1,764	1,859	1,691
Total Operating Expenses	217	211	283	261	228	310	269	262	276	205
Selling, General & Admin Expense	173	172	191	185	160	191	191	180	183	182
Research & Development Expense	68	64	62	60	60	57	59	60	65	66
Other Operating Expenses / (Income)	1.00	-	11	19	10	-2.00	13	26	3.00	5.00
Restructuring Charge	-25	-4.00	19	-3.00	-2.00	64	6.00	-4.00	25	-48
Total Other Income / (Expense), net	-43	-137	-52	-54	-57	271	-49	-50	-49	-52
Interest Expense	43	48	52	54	57	52	49	50	49	52
Income Tax Expense	-20	26	60	-3.00	20	114	49	56	99	-34
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	1.00	0.00	0.00	1.00	1.00	0.00	1.00	1.00	1.00
Basic Earnings per Share	$2.48	$0.07	$1.13	$2.28	$1.50	$2.63	$1.40	$1.96	$1.55	$2.84
Weighted Average Basic Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M
Diluted Earnings per Share	$2.46	$0.06	$1.12	$2.27	$1.49	$2.61	$1.39	$1.94	$1.53	$2.81
Weighted Average Diluted Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M
Weighted Average Basic & Diluted Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M

This table details how cash moves in and out of Eastman Chemical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	79	-112	10	35	-22	360	-105	34	55	289
Net Cash From Operating Activities	1,624	1,385	1,657	1,543	1,504	1,455	1,619	975	1,374	1,287
Net Cash From Continuing Operating Activities	1,624	1,385	1,657	1,543	1,504	1,455	1,619	975	1,374	1,287
Net Income / (Loss) Continuing Operations	854	859	1,388	1,084	762	489	867	796	896	908
Consolidated Net Income / (Loss)	854	859	1,388	1,084	762	489	867	796	896	908
Depreciation Expense	571	580	587	604	611	574	538	477	498	509
Non-Cash Adjustments To Reconcile Net Income	76	-138	-67	-21	134	338	279	-175	-209	-1.00
Changes in Operating Assets and Liabilities, net	123	84	-251	-124	-3.00	54	-65	-123	189	-129
Net Cash From Investing Activities	-693	-655	-643	-463	-480	-394	-29	392	-432	-534
Net Cash From Continuing Investing Activities	-693	-655	-643	-463	-480	-394	-29	392	-432	-534
Purchase of Property, Plant & Equipment	-652	-626	-649	-528	-431	-396	-578	-611	-828	-599
Acquisitions	-45	-26	-4.00	-3.00	-48	-1.00	-114	-1.00	-77	0.00
Sale of Property, Plant & Equipment	4.00	41	14	5.00	0.00	0.00	667	998	456	38
Other Investing Activities, net	0.00	-44	-4.00	63	-1.00	3.00	-4.00	6.00	17	27
Net Cash From Financing Activities	-844	-838	-1,006	-1,040	-1,043	-704	-1,690	-1,321	-888	-454
Net Cash From Continuing Financing Activities	-844	-838	-1,006	-1,040	-1,043	-704	-1,690	-1,321	-888	-454
Repayment of Debt	-755	-2,111	-1,044	-1,926	-765	-535	-315	-764	-1,158	-1,012
Repurchase of Common Equity	-103	-145	-350	-400	-325	-60	-1,000	-1,002	-150	-300
Payment of Dividends	-244	-280	-296	-318	-343	-358	-375	-381	-376	-379
Issuance of Debt	250	1,698	684	1,604	390	249	0.00	826	796	1,237
Effect of Exchange Rate Changes	-8.00	-4.00	2.00	-5.00	-3.00	3.00	-5.00	-12	1.00	-10

This table details how cash moves in and out of Eastman Chemical's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	5.00	32	106	-189	29	109	-49	15	108	215
Net Cash From Operating Activities	256	457	-2.00	410	514	452	-16	367	396	540
Net Cash From Continuing Operating Activities	256	457	-2.00	410	514	452	-16	367	396	540
Net Income / (Loss) Continuing Operations	301	2.00	134	272	179	311	165	231	181	331
Consolidated Net Income / (Loss)	301	2.00	134	272	179	311	165	231	181	331
Depreciation Expense	117	117	141	119	120	118	127	126	127	129
Non-Cash Adjustments To Reconcile Net Income	-16	52	-35	55	14	-243	-97	48	59	-11
Changes in Operating Assets and Liabilities, net	-146	286	-242	-36	201	266	-211	-38	29	91
Net Cash From Investing Activities	-158	-206	-252	-246	-182	248	-179	-121	-102	-132
Net Cash From Continuing Investing Activities	-158	-206	-252	-246	-182	248	-179	-121	-102	-132
Purchase of Property, Plant & Equipment	-164	-193	-176	-241	-236	-175	-186	-117	-121	-175
Other Investing Activities, net	6.00	-13	-19	-2.00	30	8.00	7.00	-4.00	19	5.00
Net Cash From Financing Activities	-88	-223	357	-353	-299	-593	148	-227	-194	-181
Net Cash From Continuing Financing Activities	-88	-223	357	-353	-299	-593	148	-227	-194	-181
Repayment of Debt	156	-358	-345	-486	-1.00	-326	-499	-32	-494	13
Repurchase of Common Equity	-150	-100	-	-	-	-100	-	-	-100	-100
Payment of Dividends	-94	-91	-94	-94	-94	-94	-95	-95	-95	-94
Effect of Exchange Rate Changes	-	4.00	3.00	-	-4.00	2.00	-	-	8.00	-12

This table presents Eastman Chemical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	15,580	15,457	10,325	15,995	16,008	16,083	15,519	14,667	14,633	15,213
Total Current Assets	2,878	2,866	191	3,365	3,321	3,541	4,646	3,778	3,481	4,101
Cash & Equivalents	293	181	191	226	204	564	459	493	548	837
Accounts Receivable	1,038	1,211	-	1,483	1,375	1,515	1,580	1,277	1,154	1,172
Inventories, net	1,479	1,404	-	1,583	1,662	1,379	1,504	1,894	1,683	1,988
Other Current Assets	68	70	-	73	80	83	1,103	114	96	104
Plant, Property, & Equipment, net	5,130	5,276	5,607	5,600	5,571	5,549	4,996	5,160	5,548	5,615
Plant, Property & Equipment, gross	11,234	11,699	-	12,731	13,081	13,531	12,680	12,942	13,574	13,985
Accumulated Depreciation	6,104	6,423	-	7,131	7,510	7,982	7,684	7,782	8,026	8,370
Total Noncurrent Assets	7,572	7,315	4,527	7,030	7,116	6,993	5,877	5,729	5,604	5,497
Goodwill	4,518	4,461	4,527	4,467	4,431	4,465	3,641	3,664	3,646	3,632
Intangible Assets	2,650	2,479	-	2,185	2,011	1,792	1,362	1,210	1,138	1,032
Other Noncurrent Operating Assets	404	375	-	378	674	736	874	855	820	833
Total Liabilities & Shareholders' Equity	15,580	15,457	6,593	15,995	16,008	16,083	15,519	14,667	14,633	15,213
Total Liabilities	11,559	10,849	0.00	10,117	9,976	9,975	9,731	9,431	9,103	9,361
Total Current Liabilities	2,056	1,795	0.00	1,851	1,789	2,038	2,971	3,251	2,576	2,708
Short-Term Debt	431	283	-	243	171	349	747	1,126	541	450
Accounts Payable	1,625	1,512	-	1,608	1,618	1,689	2,133	2,125	2,035	2,258
Other Current Nonoperating Liabilities	-	-	-	-	-	0.00	91	0.00	0.00	0.00
Total Noncurrent Liabilities	9,503	9,054	0.00	8,266	8,187	7,937	6,760	6,180	6,527	6,653
Long-Term Debt	6,577	6,311	-	5,925	5,611	5,269	4,412	4,025	4,305	4,567
Noncurrent Deferred & Payable Income Tax Liabilities	928	1,206	-	884	915	848	810	671	601	533
Noncurrent Employee Benefit Liabilities	1,297	1,018	-	925	1,016	1,143	811	628	667	630
Other Noncurrent Operating Liabilities	701	519	-	532	645	677	727	856	954	923
Total Equity & Noncontrolling Interests	4,021	4,608	6,593	5,878	6,032	6,108	5,788	5,236	5,530	5,852
Total Preferred & Common Equity	3,941	4,532	6,593	5,803	5,958	6,023	5,704	5,153	5,458	5,779
Total Common Equity	3,941	4,532	6,593	5,803	5,958	6,023	5,704	5,153	5,458	5,779
Common Stock	1,865	1,917	-	2,050	2,107	2,176	2,189	2,317	2,370	2,465
Retained Earnings	5,146	5,721	6,802	7,573	7,965	8,080	8,557	8,973	9,490	10,013
Treasury Stock	-2,680	-2,825	-	-3,575	-3,900	-3,960	-4,860	-5,932	-6,083	-6,385
Accumulated Other Comprehensive Income / (Loss)	-390	-281	-209	-245	-214	-273	-182	-205	-319	-314
Noncontrolling Interest	80	76	-	75	74	85	84	83	72	73

This table presents Eastman Chemical's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	14,985	14,667	14,983	14,771	14,594	14,633	14,748	14,945	15,060	15,213
Total Current Assets	4,105	3,778	3,973	3,671	3,567	3,481	3,638	3,842	3,937	4,101
Cash & Equivalents	461	493	599	410	439	548	499	514	622	837
Accounts Receivable	1,594	1,277	1,337	1,205	1,149	1,154	1,274	1,329	1,332	1,172
Inventories, net	1,975	1,894	1,944	1,960	1,721	1,683	1,769	1,900	1,904	1,988
Other Current Assets	75	114	93	96	258	96	96	99	79	104
Plant, Property, & Equipment, net	4,982	5,160	5,258	5,402	5,426	5,548	5,535	5,529	5,589	5,615
Plant, Property & Equipment, gross	12,645	12,942	13,153	13,361	13,382	13,574	13,651	13,717	13,916	13,985
Accumulated Depreciation	7,663	7,782	7,895	7,959	7,956	8,026	8,116	8,188	8,327	8,370
Total Noncurrent Assets	5,898	5,729	5,752	5,698	5,601	5,604	5,575	5,574	5,534	5,497
Goodwill	3,644	3,664	3,703	3,697	3,643	3,646	3,644	3,641	3,655	3,632
Intangible Assets	1,206	1,210	1,203	1,180	1,148	1,138	1,110	1,086	1,072	1,032
Other Noncurrent Operating Assets	1,048	855	846	821	810	820	821	847	807	833
Total Liabilities & Shareholders' Equity	14,985	14,667	14,983	14,771	14,594	14,633	14,748	14,945	15,060	15,213
Total Liabilities	9,518	9,431	9,721	9,419	9,170	9,103	9,140	9,246	9,332	9,361
Total Current Liabilities	3,207	3,251	2,971	2,787	2,615	2,576	2,618	2,741	2,590	2,708
Short-Term Debt	1,086	1,126	1,014	844	640	541	740	697	448	450
Accounts Payable	2,121	2,125	1,957	1,943	1,940	2,035	1,878	2,044	2,142	2,258
Other Current Nonoperating Liabilities	0.00	0.00	0.00	-	35	0.00	-	-	-	0.00
Total Noncurrent Liabilities	6,311	6,180	6,750	6,632	6,555	6,527	6,522	6,505	6,742	6,653
Long-Term Debt	3,979	4,025	4,636	4,593	4,580	4,305	4,340	4,336	4,606	4,567
Noncurrent Deferred & Payable Income Tax Liabilities	756	671	662	573	549	601	588	576	517	533
Noncurrent Employee Benefit Liabilities	746	628	629	622	611	667	663	655	652	630
Other Noncurrent Operating Liabilities	830	856	823	844	815	954	931	938	967	923
Total Equity & Noncontrolling Interests	5,467	5,236	5,262	5,352	5,424	5,530	5,608	5,699	5,728	5,852
Total Preferred & Common Equity	5,384	5,153	5,188	5,281	5,352	5,458	5,538	5,627	5,654	5,779
Total Common Equity	5,384	5,153	5,188	5,281	5,352	5,458	5,538	5,627	5,654	5,779
Common Stock	2,303	2,317	2,327	2,344	2,354	2,370	2,390	2,419	2,437	2,465
Retained Earnings	9,065	8,973	9,013	9,190	9,274	9,490	9,559	9,694	9,780	10,013
Treasury Stock	-5,832	-5,932	-5,932	-5,982	-5,982	-6,083	-6,083	-6,184	-6,285	-6,385
Accumulated Other Comprehensive Income / (Loss)	-152	-205	-220	-271	-294	-319	-328	-302	-278	-314
Noncontrolling Interest	83	83	74	71	72	72	70	72	74	73

This table displays calculated financial ratios and metrics derived from Eastman Chemical's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.27%	-6.63%	6.01%	6.30%	-8.65%	-8.63%	23.64%	0.99%	-12.95%	1.87%
EBITDA Growth	20.65%	0.31%	7.52%	1.84%	-19.71%	-24.03%	28.97%	-6.07%	33.27%	-15.83%
EBIT Growth	18.27%	-0.22%	10.15%	1.44%	-27.84%	-33.84%	56.28%	-3.63%	45.61%	-21.35%
NOPAT Growth	18.14%	8.10%	33.12%	-18.81%	-22.64%	-15.36%	28.17%	-8.01%	13.65%	0.30%
Net Income Growth	12.81%	0.59%	61.58%	-21.90%	-29.70%	-35.83%	77.30%	-8.19%	12.56%	1.34%
EPS Growth	13.88%	1.59%	64.70%	-20.17%	-27.51%	-36.13%	78.57%	1.60%	17.95%	2.40%
Operating Cash Flow Growth	13.33%	-14.72%	19.64%	-6.88%	-2.53%	-3.26%	11.27%	-39.78%	40.92%	-6.33%
Free Cash Flow Firm Growth	157.57%	-31.49%	182.68%	-119.34%	349.72%	8.02%	28.87%	1.23%	-30.08%	-23.42%
Invested Capital Growth	-1.73%	2.65%	-8.05%	16.64%	-1.78%	-3.86%	-5.22%	-6.48%	-0.67%	2.08%
Revenue Q/Q Growth	-1.27%	-0.41%	1.86%	0.14%	-1.81%	-0.22%	5.10%	-2.94%	-1.77%	0.41%
EBITDA Q/Q Growth	9.85%	3.85%	-0.24%	-4.60%	-4.26%	0.15%	14.52%	-25.46%	47.02%	7.65%
EBIT Q/Q Growth	12.62%	5.39%	-0.52%	-6.62%	-6.12%	0.82%	25.87%	-32.57%	71.59%	9.98%
NOPAT Q/Q Growth	11.34%	5.61%	25.07%	-23.74%	-1.04%	16.19%	23.78%	-28.17%	33.21%	25.81%
Net Income Q/Q Growth	14.48%	-0.81%	36.75%	-29.61%	-1.04%	1.45%	66.41%	-32.20%	52.64%	2.25%
EPS Q/Q Growth	14.11%	-0.69%	37.25%	-28.95%	-1.26%	0.57%	68.01%	-29.83%	51.62%	2.68%
Operating Cash Flow Q/Q Growth	5.87%	-11.73%	18.27%	6.49%	-4.39%	-15.41%	1.50%	2.85%	-0.36%	7.34%
Free Cash Flow Firm Q/Q Growth	174.60%	-21.72%	357.22%	-159.84%	-10.03%	-11.88%	43.03%	-29.73%	78.94%	-6.75%
Invested Capital Q/Q Growth	-1.75%	0.95%	-12.62%	-4.89%	-4.04%	-1.84%	-4.48%	-1.76%	-4.02%	-1.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	26.74%	26.17%	24.75%	24.42%	24.09%	23.31%	23.86%	20.20%	22.38%	24.41%
EBITDA Margin	20.35%	21.86%	22.17%	21.24%	18.67%	15.52%	16.19%	15.06%	23.05%	19.05%
Operating Margin	14.34%	15.34%	14.65%	14.56%	12.08%	10.24%	12.23%	10.95%	14.14%	13.62%
EBIT Margin	14.43%	15.42%	16.02%	15.29%	12.08%	8.75%	11.05%	10.55%	17.64%	13.62%
Profit (Net Income) Margin	8.85%	9.54%	14.54%	10.68%	8.22%	5.77%	8.28%	7.52%	9.73%	9.68%
Tax Burden Percent	75.64%	81.89%	107.68%	82.75%	84.48%	92.26%	80.13%	81.47%	82.43%	84.23%
Interest Burden Percent	81.11%	75.52%	84.25%	84.41%	80.54%	71.53%	93.44%	87.54%	66.89%	84.35%
Effective Tax Rate	24.36%	18.11%	-7.68%	17.25%	15.52%	7.74%	19.87%	18.53%	17.57%	15.77%
Return on Invested Capital (ROIC)	9.67%	10.40%	14.24%	11.14%	8.08%	7.03%	9.44%	9.22%	10.88%	10.84%
ROIC Less NNEP Spread (ROIC-NNEP)	6.92%	6.25%	11.86%	8.21%	4.88%	1.17%	6.20%	6.09%	6.93%	6.87%
Return on Net Nonoperating Assets (RNNOA)	12.78%	9.51%	10.54%	6.24%	4.72%	1.02%	5.13%	5.22%	5.76%	5.11%
Return on Equity (ROE)	22.44%	19.91%	24.78%	17.38%	12.80%	8.06%	14.58%	14.44%	16.65%	15.96%
Cash Return on Invested Capital (CROIC)	11.41%	7.78%	22.63%	-4.22%	9.87%	10.97%	14.81%	15.92%	11.55%	8.79%
Operating Return on Assets (OROA)	8.80%	8.95%	11.87%	11.79%	7.00%	4.62%	7.33%	7.39%	11.09%	8.56%
Return on Assets (ROA)	5.40%	5.54%	10.77%	8.24%	4.76%	3.05%	5.49%	5.27%	6.12%	6.08%
Return on Common Equity (ROCE)	21.97%	19.55%	24.62%	17.28%	12.64%	7.95%	14.37%	14.22%	16.41%	15.75%
Return on Equity Simple (ROE_SIMPLE)	21.67%	18.95%	21.05%	18.68%	12.79%	8.12%	15.20%	15.45%	16.42%	15.71%
Net Operating Profit after Tax (NOPAT)	1,047	1,132	1,506	1,223	946	801	1,026	944	1,073	1,076
NOPAT Margin	10.85%	12.56%	15.78%	12.05%	10.20%	9.45%	9.80%	8.93%	11.65%	11.47%
Net Nonoperating Expense Percent (NNEP)	2.75%	4.15%	2.38%	2.93%	3.20%	5.87%	3.24%	3.14%	3.96%	3.97%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.09%	10.34%	9.90%
Cost of Revenue to Revenue	73.26%	73.83%	75.25%	75.58%	75.91%	76.69%	76.14%	79.80%	77.62%	75.59%
SG&A Expenses to Revenue	7.99%	7.85%	7.63%	7.10%	7.45%	7.72%	7.59%	6.86%	7.89%	7.84%
R&D to Revenue	2.51%	2.48%	2.38%	2.32%	2.52%	2.67%	2.42%	2.50%	2.60%	2.66%
Operating Expenses to Revenue	12.40%	10.82%	10.10%	9.86%	11.98%	13.07%	10.46%	8.84%	11.75%	10.79%
Earnings before Interest and Taxes (EBIT)	1,392	1,389	1,530	1,552	1,120	741	1,158	1,116	1,625	1,278
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,963	1,969	2,117	2,156	1,731	1,315	1,696	1,593	2,123	1,787
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.97	1.94	1.65	1.48	1.56	2.03	2.63	1.76	1.89	1.83
Price to Tangible Book Value (P/TBV)	0.00	0.00	5.26	0.00	0.00	0.00	21.39	32.59	15.28	9.49
Price to Revenue (P/Rev)	0.81	0.98	1.14	0.84	1.00	1.44	1.43	0.86	1.12	1.13
Price to Earnings (P/E)	9.17	10.29	7.85	7.93	12.27	25.59	17.50	11.47	11.52	11.70
Dividend Yield	3.17%	3.16%	2.76%	3.76%	3.68%	2.96%	2.54%	4.05%	3.66%	3.57%
Earnings Yield	10.91%	9.72%	12.74%	12.61%	8.15%	3.91%	5.72%	8.72%	8.68%	8.55%
Enterprise Value to Invested Capital (EV/IC)	1.36	1.39	1.05	1.23	1.29	1.56	1.87	1.40	1.49	1.48
Enterprise Value to Revenue (EV/Rev)	1.51	1.70	1.12	1.44	1.61	2.05	1.89	1.31	1.59	1.58
Enterprise Value to EBITDA (EV/EBITDA)	7.42	7.76	5.04	6.76	8.65	13.21	11.66	8.68	6.91	8.30
Enterprise Value to EBIT (EV/EBIT)	10.47	11.00	6.98	9.40	13.36	23.44	17.08	12.40	9.03	11.61
Enterprise Value to NOPAT (EV/NOPAT)	13.92	13.50	7.09	11.92	15.82	21.69	19.27	14.65	13.67	13.78
Enterprise Value to Operating Cash Flow (EV/OCF)	8.97	11.03	6.44	9.45	9.95	11.94	12.22	14.19	10.68	11.53
Enterprise Value to Free Cash Flow (EV/FCFF)	11.79	18.04	4.46	0.00	12.95	13.91	12.29	8.49	12.88	17.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.74	1.43	0.00	1.05	0.96	0.92	0.89	0.98	0.88	0.86
Long-Term Debt to Equity	1.64	1.37	0.00	1.01	0.93	0.86	0.76	0.77	0.78	0.78
Financial Leverage	1.85	1.52	0.89	0.76	0.97	0.88	0.83	0.86	0.83	0.74
Leverage Ratio	4.16	3.60	2.30	2.11	2.69	2.64	2.66	2.74	2.72	2.62
Compound Leverage Factor	3.37	2.72	1.94	1.78	2.16	1.89	2.48	2.40	1.82	2.21
Debt to Total Capital	63.54%	58.86%	0.00%	51.20%	48.94%	47.91%	47.13%	49.59%	46.70%	46.16%
Short-Term Debt to Total Capital	3.91%	2.53%	0.00%	2.02%	1.45%	2.98%	6.82%	10.84%	5.21%	4.14%
Long-Term Debt to Total Capital	59.63%	56.34%	0.00%	49.19%	47.49%	44.93%	40.30%	38.75%	41.49%	42.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.73%	0.68%	0.00%	0.62%	0.63%	0.72%	0.77%	0.80%	0.69%	0.67%
Common Equity to Total Capital	35.73%	40.46%	100.00%	48.17%	50.43%	51.36%	52.11%	49.61%	52.60%	53.17%
Debt to EBITDA	3.57	3.35	0.00	2.86	3.34	4.27	3.04	3.23	2.28	2.81
Net Debt to EBITDA	3.42	3.26	0.00	2.76	3.22	3.84	2.77	2.92	2.02	2.34
Long-Term Debt to EBITDA	3.35	3.21	0.00	2.75	3.24	4.01	2.60	2.53	2.03	2.56
Debt to NOPAT	6.69	5.83	0.00	5.04	6.11	7.02	5.03	5.45	4.52	4.66
Net Debt to NOPAT	6.41	5.67	0.00	4.86	5.90	6.31	4.58	4.93	4.00	3.88
Long-Term Debt to NOPAT	6.28	5.58	0.00	4.84	5.93	6.58	4.30	4.26	4.01	4.24
Altman Z-Score	1.84	1.97	0.00	2.24	2.18	2.23	2.75	2.45	2.66	2.60
Noncontrolling Interest Sharing Ratio	2.10%	1.81%	0.68%	0.60%	1.25%	1.31%	1.42%	1.51%	1.44%	1.27%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.40	1.60	0.00	1.82	1.86	1.74	1.56	1.16	1.35	1.51
Quick Ratio	0.65	0.78	0.00	0.92	0.88	1.02	0.69	0.54	0.66	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,236	847	2,393	-463	1,156	1,249	1,609	1,629	1,139	872
Operating Cash Flow to CapEx	250.62%	236.75%	260.94%	295.03%	348.96%	367.42%	0.00%	0.00%	369.35%	229.41%
Free Cash Flow to Firm to Interest Expense	4.70	2.49	9.93	-1.91	5.30	5.92	8.09	8.95	5.30	4.36
Operating Cash Flow to Interest Expense	6.17	4.07	6.88	6.38	6.90	6.90	8.14	5.36	6.39	6.44
Operating Cash Flow Less CapEx to Interest Expense	3.71	2.35	4.24	4.21	4.92	5.02	8.58	7.48	4.66	3.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.58	0.74	0.77	0.58	0.53	0.66	0.70	0.63	0.63
Accounts Receivable Turnover	8.62	8.01	0.00	0.00	6.49	5.86	6.77	7.41	7.58	8.07
Inventory Turnover	4.73	4.61	0.00	0.00	4.34	4.27	5.53	4.97	4.00	3.86
Fixed Asset Turnover	1.89	1.73	1.75	1.81	1.66	1.52	1.99	2.08	1.72	1.68
Accounts Payable Turnover	4.22	4.24	0.00	0.00	4.36	3.93	4.17	3.97	3.44	3.30
Days Sales Outstanding (DSO)	42.33	45.56	0.00	0.00	56.25	62.25	53.92	49.28	48.17	45.25
Days Inventory Outstanding (DIO)	77.15	79.11	0.00	0.00	84.13	85.41	65.97	73.45	91.31	94.47
Days Payable Outstanding (DPO)	86.40	86.08	0.00	0.00	83.64	92.88	87.45	92.04	106.20	110.47
Cash Conversion Cycle (CCC)	33.09	38.59	0.00	0.00	56.74	54.78	32.43	30.69	33.29	29.24
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,736	11,021	10,134	11,820	11,610	11,162	10,579	9,894	9,828	10,032
Invested Capital Turnover	0.89	0.83	0.90	0.92	0.79	0.74	0.96	1.03	0.93	0.94
Increase / (Decrease) in Invested Capital	-189	285	-887	1,686	-210	-448	-583	-685	-66	204
Enterprise Value (EV)	14,571	15,275	10,677	14,583	14,968	17,369	19,779	13,833	14,671	14,838
Market Capitalization	7,776	8,786	10,868	8,566	9,316	12,230	14,995	9,092	10,301	10,585
Book Value per Share	$26.52	$30.88	$45.87	$41.44	$43.82	$44.46	$42.43	$42.95	$46.03	$49.86
Tangible Book Value per Share	($21.71)	($16.41)	$14.37	($6.06)	($3.56)	($1.73)	$5.21	$2.33	$5.68	$9.62
Total Capital	11,029	11,202	6,593	12,046	11,814	11,726	10,947	10,387	10,376	10,869
Total Debt	7,008	6,594	0.00	6,168	5,782	5,618	5,159	5,151	4,846	5,017
Total Long-Term Debt	6,577	6,311	0.00	5,925	5,611	5,269	4,412	4,025	4,305	4,567
Net Debt	6,715	6,413	-191	5,942	5,578	5,054	4,700	4,658	4,298	4,180
Capital Expenditures (CapEx)	648	585	635	523	431	396	-89	-387	372	561
Debt-free, Cash-free Net Working Capital (DFCFNWC)	960	1,173	0.00	1,531	1,499	1,288	1,963	1,160	898	1,006
Debt-free Net Working Capital (DFNWC)	1,253	1,354	191	1,757	1,703	1,852	2,422	1,653	1,446	1,843
Net Working Capital (NWC)	822	1,071	191	1,514	1,532	1,503	1,675	527	905	1,393
Net Nonoperating Expense (NNE)	193	273	118	139	184	312	159	148	177	168
Net Nonoperating Obligations (NNO)	6,715	6,413	3,541	5,942	5,578	5,054	4,791	4,658	4,298	4,180
Total Depreciation and Amortization (D&A)	571	580	587	604	611	574	538	477	498	509
Debt-free, Cash-free Net Working Capital to Revenue	9.95%	13.02%	0.00%	15.08%	16.17%	15.20%	18.74%	10.96%	9.75%	10.72%
Debt-free Net Working Capital to Revenue	12.99%	15.03%	2.00%	17.31%	18.37%	21.86%	23.12%	15.62%	15.70%	19.64%
Net Working Capital to Revenue	8.52%	11.89%	2.00%	14.91%	16.52%	17.74%	15.99%	4.98%	9.83%	14.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.71	$5.80	$9.56	$7.65	$5.52	$3.53	$6.35	$6.42	$7.54	$7.75
Adjusted Weighted Average Basic Shares Outstanding	147.81M	146.49M	142.97M	139.78M	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Adjusted Diluted Earnings per Share	$5.66	$5.75	$9.47	$7.56	$5.48	$3.50	$6.25	$6.35	$7.49	$7.67
Adjusted Weighted Average Diluted Shares Outstanding	147.81M	146.49M	142.97M	139.78M	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	147.81M	146.49M	142.97M	139.78M	135.99M	271.72M	257.94M	237.59M	234.69M	115.17M
Normalized Net Operating Profit after Tax (NOPAT)	1,185	1,169	985	1,260	1,053	1,010	1,064	904	1,138	1,059
Normalized NOPAT Margin	12.29%	12.97%	10.31%	12.42%	11.35%	11.92%	10.16%	8.55%	12.35%	11.29%
Pre Tax Income Margin	11.70%	11.65%	13.50%	12.91%	9.73%	6.26%	10.33%	9.23%	11.80%	11.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.29	4.09	6.35	6.41	5.14	3.51	5.82	6.13	7.56	6.39
NOPAT to Interest Expense	3.98	3.33	6.25	5.05	4.34	3.80	5.16	5.19	4.99	5.38
EBIT Less CapEx to Interest Expense	2.83	2.36	3.71	4.25	3.16	1.64	6.27	8.26	5.83	3.59
NOPAT Less CapEx to Interest Expense	1.52	1.61	3.62	2.89	2.36	1.92	5.61	7.31	3.26	2.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.57%	32.60%	21.33%	29.34%	45.01%	73.21%	43.25%	47.86%	41.96%	41.74%
Augmented Payout Ratio	40.63%	49.48%	46.54%	66.24%	87.66%	85.48%	158.59%	173.74%	58.71%	74.78%

This table displays calculated financial ratios and metrics derived from Eastman Chemical's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.40%	-11.92%	-11.13%	-16.52%	-16.32%	-7.00%	-4.23%	1.68%	8.69%	1.72%
EBITDA Growth	-11.27%	-67.70%	-14.76%	-19.34%	-14.74%	148.95%	0.78%	4.75%	21.28%	-19.66%
EBIT Growth	-12.43%	-80.26%	-26.13%	-24.18%	-20.99%	290.98%	6.91%	4.33%	28.52%	-26.83%
NOPAT Growth	-14.94%	-98.04%	-28.00%	13.66%	-33.65%	3,905.51%	19.34%	-16.95%	-7.64%	11.43%
Net Income Growth	-14.97%	-99.47%	-43.22%	5.84%	-40.53%	15,450.00%	23.13%	-15.07%	1.12%	6.43%
EPS Growth	-4.28%	-97.83%	-37.78%	11.82%	-39.43%	4,250.00%	24.11%	-14.54%	2.68%	7.66%
Operating Cash Flow Growth	-53.20%	6.28%	-111.76%	67.35%	100.78%	-1.09%	-700.00%	-10.49%	-22.96%	19.47%
Free Cash Flow Firm Growth	91.90%	-32.45%	37.81%	-107.83%	-95.46%	-40.17%	-59.60%	491.53%	377.67%	-55.44%
Invested Capital Growth	-9.07%	-6.48%	-5.83%	4.40%	1.68%	-0.67%	-1.20%	-1.55%	-0.78%	2.08%
Revenue Q/Q Growth	-2.69%	-12.40%	1.64%	-3.65%	-2.45%	-2.65%	4.67%	2.29%	4.27%	-8.89%
EBITDA Q/Q Growth	-19.53%	-45.81%	61.92%	14.21%	-14.93%	58.24%	11.11%	18.72%	-1.51%	4.82%
EBIT Q/Q Growth	-23.94%	-62.35%	101.64%	31.30%	-20.74%	86.33%	12.88%	28.14%	-2.37%	6.08%
NOPAT Q/Q Growth	20.78%	-97.49%	1,849.87%	92.21%	-29.49%	51.58%	18.93%	33.76%	-21.59%	82.89%
Net Income Q/Q Growth	17.12%	-99.34%	6,600.00%	102.99%	-34.19%	73.74%	-46.95%	40.00%	-21.65%	82.87%
EPS Q/Q Growth	21.18%	-97.56%	1,766.67%	102.68%	-34.36%	75.17%	-46.74%	39.57%	-21.13%	83.66%
Operating Cash Flow Q/Q Growth	4.49%	78.52%	-100.44%	20,600.00%	25.37%	-12.06%	-103.54%	2,393.75%	7.90%	36.36%
Free Cash Flow Firm Q/Q Growth	-4.14%	-48.65%	16.61%	-113.65%	155.50%	577.40%	38.17%	32.27%	-32.29%	-36.81%
Invested Capital Q/Q Growth	1.30%	-1.76%	4.23%	0.64%	-1.34%	-4.02%	3.67%	0.28%	-0.57%	-1.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.97%	15.84%	21.93%	25.13%	21.35%	21.02%	23.03%	25.35%	24.55%	24.68%
EBITDA Margin	16.28%	10.07%	16.04%	19.02%	16.59%	26.96%	16.88%	19.59%	18.51%	21.29%
Operating Margin	11.96%	5.14%	10.20%	13.90%	11.29%	21.61%	11.39%	14.26%	13.35%	15.55%
EBIT Margin	11.96%	5.14%	10.20%	13.90%	11.29%	21.61%	11.39%	14.26%	13.35%	15.55%
Profit (Net Income) Margin	11.11%	0.08%	5.56%	11.70%	7.90%	14.09%	7.14%	9.78%	7.35%	14.74%
Tax Burden Percent	107.12%	7.14%	69.07%	101.12%	89.95%	73.18%	77.10%	80.49%	64.64%	111.45%
Interest Burden Percent	86.73%	22.95%	78.86%	83.28%	77.73%	89.10%	81.37%	85.16%	85.11%	85.10%
Effective Tax Rate	-7.12%	92.86%	30.93%	-1.12%	10.05%	26.82%	22.90%	19.51%	35.36%	-11.45%
Return on Invested Capital (ROIC)	13.21%	0.38%	6.81%	13.58%	9.38%	14.77%	7.80%	10.20%	7.91%	16.37%
ROIC Less NNEP Spread (ROIC-NNEP)	12.24%	0.24%	6.09%	12.44%	8.29%	13.92%	7.02%	9.35%	7.22%	15.00%
Return on Net Nonoperating Assets (RNNOA)	9.93%	0.20%	5.44%	11.05%	7.17%	11.58%	6.22%	8.08%	5.99%	11.17%
Return on Equity (ROE)	23.14%	0.58%	12.25%	24.63%	16.55%	26.35%	14.02%	18.27%	13.90%	27.54%
Cash Return on Invested Capital (CROIC)	21.93%	15.92%	14.26%	4.87%	6.27%	11.55%	9.99%	9.89%	9.17%	8.79%
Operating Return on Assets (OROA)	8.35%	3.60%	6.81%	9.21%	7.16%	13.59%	6.98%	8.78%	8.41%	9.77%
Return on Assets (ROA)	7.75%	0.06%	3.71%	7.75%	5.01%	8.86%	4.38%	6.02%	4.63%	9.27%
Return on Common Equity (ROCE)	22.80%	0.57%	12.07%	24.28%	16.31%	25.97%	13.83%	18.04%	13.71%	27.19%
Return on Equity Simple (ROE_SIMPLE)	21.81%	0.00%	13.38%	13.43%	10.97%	0.00%	16.74%	15.75%	15.71%	0.00%
Net Operating Profit after Tax (NOPAT)	347	8.71	170	327	230	349	203	271	213	389
NOPAT Margin	12.81%	0.37%	7.04%	14.05%	10.16%	15.82%	8.78%	11.48%	8.63%	17.33%
Net Nonoperating Expense Percent (NNEP)	0.97%	0.14%	0.72%	1.14%	1.09%	0.85%	0.78%	0.84%	0.69%	1.37%
Return On Investment Capital (ROIC_SIMPLE)	-	0.08%	-	-	-	3.36%	-	-	-	3.58%
Cost of Revenue to Revenue	80.03%	84.16%	78.07%	74.87%	78.65%	78.98%	76.97%	74.65%	75.45%	75.32%
SG&A Expenses to Revenue	6.39%	7.25%	7.92%	7.96%	7.06%	8.65%	8.27%	7.62%	7.43%	8.11%
R&D to Revenue	2.51%	2.70%	2.57%	2.58%	2.65%	2.58%	2.55%	2.54%	2.64%	2.94%
Operating Expenses to Revenue	8.01%	8.89%	11.73%	11.23%	10.06%	14.05%	11.65%	11.09%	11.20%	9.13%
Earnings before Interest and Taxes (EBIT)	324	122	246	323	256	477	263	337	329	349
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	441	239	387	442	376	595	390	463	456	478
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.53	1.76	1.86	1.82	1.64	1.89	2.15	2.05	2.31	1.83
Price to Tangible Book Value (P/TBV)	15.44	32.59	34.22	23.81	15.67	15.28	15.16	12.81	14.11	9.49
Price to Revenue (P/Rev)	0.76	0.86	0.94	0.98	0.94	1.12	1.30	1.26	1.40	1.13
Price to Earnings (P/E)	7.05	11.47	13.94	13.59	15.03	11.52	12.85	13.05	14.78	11.70
Dividend Yield	4.53%	4.05%	3.82%	3.88%	4.26%	3.66%	3.19%	3.29%	2.89%	3.57%
Earnings Yield	14.19%	8.72%	7.17%	7.36%	6.65%	8.68%	7.78%	7.66%	6.76%	8.55%
Enterprise Value to Invested Capital (EV/IC)	1.28	1.40	1.43	1.42	1.33	1.49	1.62	1.58	1.73	1.48
Enterprise Value to Revenue (EV/Rev)	1.19	1.31	1.44	1.50	1.46	1.59	1.82	1.76	1.88	1.58
Enterprise Value to EBITDA (EV/EBITDA)	6.05	8.68	9.15	9.75	9.45	6.91	10.61	10.20	10.60	8.30
Enterprise Value to EBIT (EV/EBIT)	7.81	12.40	13.21	14.50	14.41	9.03	15.38	14.80	15.14	11.61
Enterprise Value to NOPAT (EV/NOPAT)	9.84	14.65	16.83	15.79	16.94	13.67	18.37	18.79	20.56	13.78
Enterprise Value to Operating Cash Flow (EV/OCF)	13.64	14.19	15.45	13.13	9.90	10.68	12.16	12.24	14.67	11.53
Enterprise Value to Free Cash Flow (EV/FCFF)	5.58	8.49	9.74	29.73	21.43	12.88	16.14	15.82	18.80	17.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.93	0.98	1.07	1.02	0.96	0.88	0.91	0.88	0.88	0.86
Long-Term Debt to Equity	0.73	0.77	0.88	0.86	0.84	0.78	0.77	0.76	0.80	0.78
Financial Leverage	0.81	0.86	0.89	0.89	0.86	0.83	0.89	0.86	0.83	0.74
Leverage Ratio	2.68	2.74	2.74	2.76	2.72	2.72	2.74	2.69	2.66	2.62
Compound Leverage Factor	2.32	0.63	2.16	2.29	2.11	2.42	2.23	2.29	2.26	2.23
Debt to Total Capital	48.09%	49.59%	51.78%	50.39%	49.04%	46.70%	47.53%	46.90%	46.87%	46.16%
Short-Term Debt to Total Capital	10.31%	10.84%	9.29%	7.82%	6.01%	5.21%	6.92%	6.49%	4.16%	4.14%
Long-Term Debt to Total Capital	37.78%	38.75%	42.49%	42.57%	43.03%	41.49%	40.61%	40.40%	42.72%	42.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.79%	0.80%	0.68%	0.66%	0.68%	0.69%	0.65%	0.67%	0.69%	0.67%
Common Equity to Total Capital	51.12%	49.61%	47.54%	48.95%	50.28%	52.60%	51.82%	52.43%	52.44%	53.17%
Debt to EBITDA	2.37	3.23	3.50	3.60	3.62	2.28	3.26	3.19	3.04	2.81
Net Debt to EBITDA	2.15	2.92	3.13	3.33	3.31	2.02	2.94	2.86	2.67	2.34
Long-Term Debt to EBITDA	1.86	2.53	2.87	3.04	3.17	2.03	2.78	2.74	2.77	2.56
Debt to NOPAT	3.85	5.45	6.44	5.83	6.48	4.52	5.64	5.87	5.91	4.66
Net Debt to NOPAT	3.50	4.93	5.75	5.39	5.93	4.00	5.09	5.27	5.18	3.88
Long-Term Debt to NOPAT	3.03	4.26	5.28	4.93	5.68	4.01	4.82	5.06	5.38	4.24
Altman Z-Score	2.24	2.23	2.26	2.29	2.24	2.40	2.45	2.43	2.55	2.40
Noncontrolling Interest Sharing Ratio	1.46%	1.51%	1.41%	1.44%	1.42%	1.44%	1.32%	1.29%	1.31%	1.27%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.28	1.16	1.34	1.32	1.36	1.35	1.39	1.40	1.52	1.51
Quick Ratio	0.64	0.54	0.65	0.58	0.61	0.66	0.68	0.67	0.75	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,351	694	809	-110	61	415	327	432	293	185
Operating Cash Flow to CapEx	156.10%	236.79%	-1.14%	170.12%	217.80%	258.29%	-8.60%	313.68%	327.27%	308.57%
Free Cash Flow to Firm to Interest Expense	31.42	14.45	15.56	-2.04	1.07	7.98	6.67	8.64	5.97	3.56
Operating Cash Flow to Interest Expense	5.95	9.52	-0.04	7.59	9.02	8.69	-0.33	7.34	8.08	10.38
Operating Cash Flow Less CapEx to Interest Expense	2.14	5.50	-3.42	3.13	4.88	5.33	-4.12	5.00	5.61	7.02
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.70	0.70	0.67	0.66	0.63	0.63	0.61	0.62	0.63	0.63
Accounts Receivable Turnover	6.60	7.41	6.89	6.91	6.84	7.58	6.98	7.22	7.53	8.07
Inventory Turnover	4.76	4.97	4.52	4.11	4.01	4.00	3.79	3.66	3.94	3.86
Fixed Asset Turnover	2.15	2.08	2.00	1.90	1.80	1.72	1.69	1.67	1.70	1.68
Accounts Payable Turnover	4.20	3.97	4.07	3.79	3.65	3.44	3.67	3.55	3.50	3.30
Days Sales Outstanding (DSO)	55.26	49.28	53.00	52.79	53.39	48.17	52.32	50.56	48.46	45.25
Days Inventory Outstanding (DIO)	76.67	73.45	80.83	88.72	91.11	91.31	96.20	99.67	92.60	94.47
Days Payable Outstanding (DPO)	87.01	92.04	89.66	96.36	100.11	106.20	99.36	102.95	104.28	110.47
Cash Conversion Cycle (CCC)	44.93	30.69	44.17	45.15	44.39	33.29	49.16	47.28	36.78	29.24
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,071	9,894	10,313	10,379	10,240	9,828	10,189	10,218	10,160	10,032
Invested Capital Turnover	1.03	1.03	0.97	0.97	0.92	0.93	0.89	0.89	0.92	0.94
Increase / (Decrease) in Invested Capital	-1,004	-685	-639	437	169	-66	-124	-161	-80	204
Enterprise Value (EV)	12,932	13,833	14,774	14,719	13,646	14,671	16,533	16,117	17,589	14,838
Market Capitalization	8,245	9,092	9,649	9,621	8,793	10,301	11,882	11,526	13,083	10,585
Book Value per Share	$43.84	$42.95	$43.67	$44.32	$45.14	$46.03	$47.07	$47.83	$48.38	$49.86
Tangible Book Value per Share	$4.35	$2.33	$2.37	$3.39	$4.73	$5.68	$6.66	$7.65	$7.93	$9.62
Total Capital	10,532	10,387	10,912	10,789	10,644	10,376	10,688	10,732	10,782	10,869
Total Debt	5,065	5,151	5,650	5,437	5,220	4,846	5,080	5,033	5,054	5,017
Total Long-Term Debt	3,979	4,025	4,636	4,593	4,580	4,305	4,340	4,336	4,606	4,567
Net Debt	4,604	4,658	5,051	5,027	4,781	4,298	4,581	4,519	4,432	4,180
Capital Expenditures (CapEx)	164	193	176	241	236	175	186	117	121	175
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,523	1,160	1,417	1,318	1,153	898	1,261	1,284	1,173	1,006
Debt-free Net Working Capital (DFNWC)	1,984	1,653	2,016	1,728	1,592	1,446	1,760	1,798	1,795	1,843
Net Working Capital (NWC)	898	527	1,002	884	952	905	1,020	1,101	1,347	1,393
Net Nonoperating Expense (NNE)	46	6.71	36	55	51	38	38	40	32	58
Net Nonoperating Obligations (NNO)	4,604	4,658	5,051	5,027	4,816	4,298	4,581	4,519	4,432	4,180
Total Depreciation and Amortization (D&A)	117	117	141	119	120	118	127	126	127	129
Debt-free, Cash-free Net Working Capital to Revenue	13.97%	10.96%	13.79%	13.42%	12.30%	9.75%	13.85%	14.04%	12.55%	10.72%
Debt-free Net Working Capital to Revenue	18.20%	15.62%	19.61%	17.60%	16.98%	15.70%	19.32%	19.66%	19.21%	19.64%
Net Working Capital to Revenue	8.24%	4.98%	9.75%	9.00%	10.15%	9.83%	11.20%	12.04%	14.42%	14.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.48	$0.07	$1.13	$2.28	$1.50	$2.63	$1.40	$1.96	$1.55	$2.84
Adjusted Weighted Average Basic Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M
Adjusted Diluted Earnings per Share	$2.46	$0.06	$1.12	$2.27	$1.49	$2.61	$1.39	$1.94	$1.53	$2.81
Adjusted Weighted Average Diluted Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	239.98M	237.59M	238.30M	118.56M	118.56M	234.69M	117.65M	116.86M	115.91M	115.17M
Normalized Net Operating Profit after Tax (NOPAT)	209	83	183	224	228	396	207	268	229	211
Normalized NOPAT Margin	7.73%	3.48%	7.59%	9.64%	10.08%	17.94%	8.98%	11.34%	9.29%	9.39%
Pre Tax Income Margin	10.37%	1.18%	8.04%	11.57%	8.78%	19.26%	9.26%	12.15%	11.36%	13.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.53	2.54	4.73	5.98	4.49	9.17	5.37	6.74	6.71	6.71
NOPAT to Interest Expense	8.07	0.18	3.27	6.05	4.04	6.71	4.14	5.42	4.34	7.48
EBIT Less CapEx to Interest Expense	3.72	-1.48	1.35	1.52	0.35	5.81	1.57	4.40	4.24	3.35
NOPAT Less CapEx to Interest Expense	4.26	-3.84	-0.12	1.59	-0.10	3.35	0.34	3.08	1.87	4.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	32.62%	47.86%	54.32%	52.61%	63.54%	41.96%	40.67%	42.66%	42.68%	41.74%
Augmented Payout Ratio	169.93%	173.74%	54.32%	94.92%	89.10%	58.71%	40.67%	65.24%	76.46%	74.78%

Frequently Asked Questions About Eastman Chemical's Financials

When does Eastman Chemical's fiscal year end?

According to the most recent income statement we have on file, Eastman Chemical's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Eastman Chemical's net income changed over the last 9 years?

Eastman Chemical's net income appears to be on a downward trend, with a most recent value of $908 million in 2024, rising from $854 million in 2015. The previous period was $896 million in 2023.

What is Eastman Chemical's operating income?

Eastman Chemical's total operating income in 2024 was $1.28 billion, based on the following breakdown:

Total Gross Profit: $2.29 billion
Total Operating Expenses: $1.01 billion

How has Eastman Chemical revenue changed over the last 9 years?

Over the last 9 years, Eastman Chemical's total revenue changed from $9.65 billion in 2015 to $9.38 billion in 2024, a change of -2.8%.

How much debt does Eastman Chemical have?

Eastman Chemical's total liabilities were at $9.36 billion at the end of 2024, a 2.8% increase from 2023, and a 19.0% decrease since 2015.

How much cash does Eastman Chemical have?

In the past 9 years, Eastman Chemical's cash and equivalents has ranged from $181 million in 2016 to $837 million in 2024, and is currently $837 million as of their latest financial filing in 2024.

How has Eastman Chemical's book value per share changed over the last 9 years?

Over the last 9 years, Eastman Chemical's book value per share changed from 26.52 in 2015 to 49.86 in 2024, a change of 88.0%.

Related Companies

This page (NYSE:EMN) was last updated on 4/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Eastman Chemical (EMN) Financials

Frequently Asked Questions About Eastman Chemical's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Eastman Chemical (EMN) Financials

Annual Income Statements for Eastman Chemical

Quarterly Income Statements for Eastman Chemical

Annual Cash Flow Statements for Eastman Chemical

Quarterly Cash Flow Statements for Eastman Chemical

Annual Balance Sheets for Eastman Chemical

Quarterly Balance Sheets for Eastman Chemical

Annual Metrics and Ratios for Eastman Chemical

Quarterly Metrics and Ratios for Eastman Chemical

Frequently Asked Questions About Eastman Chemical's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools